GREENYN BIOTECHNOLOGY CO., LTD
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
GREENYN’s product portfolio includes proprietary and third‑party dietary‑supplement ingredients — such as the patented bitter‑melon peptide Insumate®, the Antrodia‑based Antromax®, and the plant‑fermented drink Zymologist® 101 Phyto Fermented Drink — each
The content above was translated by Ai
Founded Year
2012
Unified Business No.
54059626
Status
Active
Number of Employees
150
Total Paid-in
Capital
270,660,390 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
OTC listing(2023)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Biotechnology is a leading international developer and manufacturer of dietary‑supplement raw materials, offering one‑stop OEM/ODM/CDMO services from raw‑material sourcing and formulation design to manufacturing, with a mission to deliver high‑value, market‑differentiated health products.
The content above was translated by Ai
